Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:918-927
doi: 10.1161/CIRCULATIONAHA.106.660639
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.
Related Collections
Right arrow Congestive
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Energy metabolism
Right arrow Imaging
Right arrow Nuclear cardiology and PET

(Circulation. 2007;115:918-927.)
© 2007 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Myocardial Energetics and Efficiency

Current Status of the Noninvasive Approach

Paul Knaapen, MD, PhD; Tjeerd Germans, MD; Juhani Knuuti, MD, PhD; Walter J. Paulus, MD, PhD; Pieter A. Dijkmans, MD; Cornelis P. Allaart, MD, PhD; Adriaan A. Lammertsma, PhD; Frans C. Visser, MD, PhD

From the Department of Cardiology (P.K., T.G., P.A.D., C.P.A., F.C.V.), the Laboratory of Physiology (W.J.P.), and the Department of Nuclear Medicine & PET Research (A.A.L.), VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, The Netherlands, and the Turku PET Center (J.K.), University of Turku, Turku, Finland.

Correspondence to Dr Paul Knaapen, Department of Cardiology, 6D 120, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. E-mail p.knaapen@vumc.nl


Key Words: hemodynamics • imaging • metabolism


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
The heart is an aerobic organ that relies almost exclusively on the aerobic oxidation of substrates for generation of energy. Consequently, there is close coupling between myocardial oxygen consumption (MVO2) and the main determinants of systolic function: heart rate, contractile state, and wall stress.1 As in any mechanical pump, only part of the energy invested is converted to external power. In the case of the heart, the ratio of useful energy produced (ie, stroke work [SW]) to oxygen consumed is defined as mechanical efficiency, as originally proposed by Bing et al.2 Under normal conditions this ratio is {approx}25%, and the residual energy mainly dissipates as heat.3 In pathophysiological disease states, such as heart failure, mechanical efficiency is reduced, and it has been hypothesized that the increased energy expenditure relative to work contributes to progression of the disease.4,5 Moreover, therapeutic interventions that enhance mechanical efficiency have proven to be beneficial with respect to outcome.6 It is therefore desirable to quantify efficiency of the heart to study disease processes and monitor interventions.

Both cardiac oxidative metabolism and mechanical work, and thus efficiency, can be quantified through invasive measurements. Although these measurements are accurate and currently considered the gold standard, in clinical practice they are limited because of the need for dual-sided heart catheterization and selective catheterization of the coronary sinus. Recent advances in imaging techniques, however, offer the possibility to noninvasively estimate MVO2 and mechanical work by positron emission tomography and echocardiography or by magnetic resonance imaging, respectively.

This . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. N. Hawkins, Q. Barnes, S. Purkayastha, W. Eubank, S. Ogoh, and P. B. Raven
The effects of aerobic fitness and {beta}1-adrenergic receptor blockade on cardiac work during dynamic exercise
J Appl Physiol, February 1, 2009; 106(2): 486 - 493.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A.H. Stewart, O. C. Raffel, A. J. Kerr, R. Gabriel, I. Zeng, A. A. Young, and B. R. Cowan
Pilot Study to Assess the Influence of {beta}-Blockade on Mitral Regurgitant Volume and Left Ventricular Work in Degenerative Mitral Valve Disease
Circulation, September 2, 2008; 118(10): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation, July 24, 2007; 116(4): 434 - 448.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Oh, J.-H. Chung, S.-M. Kang, S. W. Smith, D. Niederseer, C. Thaler, J. Niebauer, P. Korantzopoulos, J. A. Goudevenos, P. Knaapen, et al.
The Failing Heart
N. Engl. J. Med., June 14, 2007; 356(24): 2544 - 2546.
[Full Text] [PDF]